View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 420 / Trastuzumab 6 / Letrozole 2.5, Breast Cancer, Neoadjuvant, Cycle 2-4
Protocol-ID: 2434 V1.1 (Mini), PERT420/TRAS6/LETR2.5, Breast Ca, neoadj, C2-4Indication(s)
- Breast Cancer (HR+, HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 09.10.2024